Company / Gross Profit
Insulet Corporation Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$1.9B
FY2025
5-year range
$480.3M / $1.9B
FY2021-FY2025
Trend
+34.2%
vs FY2024
Sector context
#27 of 100
Health Care
What the data says
At $1.9B, Insulet Corporation's gross profit ranks #27 of 100 in the Health Care sector. Gross Profit has increased for 6 consecutive years, from $277M in FY2019 to $1.9B in FY2025.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +39.3%.
Improved from $1.2B to $1.9B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +49.4%
- 5-Year CAGR
- +39.3%
- 10-Year CAGR
- -
Sector benchmark
#27 of 100 in Health CareTop 27% of 100This company $1.9B Sector average $1.8B
▼
+6.8% above sector average
Key checks
Key Insights
- Insulet Corporation's gross profit has grown for 6 consecutive years.
- 5-year CAGR of +39.3%, indicating consistent growth.
- In FY2025, gross profit increased 34.2% year-over-year.
- Ranks #27 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | +34.2% |
| FY2024 | $1.4B | +24.6% |
| FY2023 | $1.2B | +99.2% |
| FY2022 | $582.3M | +21.2% |
| FY2021 | $480.3M | +29.7% |
| FY2020 | $370.2M | +33.5% |
| FY2019 | $277.2M | -25.1% |
| FY2018 | $370.2M | +33.5% |
| FY2017 | $277.2M | +31.3% |
| FY2016 | $211.1M | +58.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026